The growing demand for precise immunological research and therapeutic design has spurred significant improvements in recombinant signal molecule manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently generated using multiple expression platforms, including prokaryotic hosts, mammalian cell cultures, and b